Recombinant Rat Cd22 protein, Fc-tagged, APC labeled

• Cat.No.: Cd22-1153RA
• Product Overview: Recombinant Rat Cd22 protein, Fc-tagged was Conjugated with NH2-Reactive APC(Allophycocyanin).

Specification

• Description: NH2-Reactive Allophycocyanin is used for antibody conjugation for immunostaining and cellular proteins for tracing. NH2-Reactive Allophycocyanin has succinimidyl ester groups, and can easily make a covalent bond with amino groups of protein without any activation process.
• Source: HEK293
• Species: Rat
• Tag: Fc
• Form: Liquid in sterile PBS buffer pH 7.4 (may contains tiny amount of reaction buffer and Allophycocyanin).
• Endotoxin: <1EU/ug by LAL method.
• Stability: Sample is stable for at least 12 months when stored at -20 to -80°C from date of manufacture. For longer storage, add equal volume of glycerol to the sample solution and store at -20 to -80°C.
• Storage: Store under sterile conditions at -20 to -80°C immediately after receipt. It is recommended that the protein be aliquoted for optimal storage. Avoid freeze-thaw cycles.
• Related Product: Cd22-1153R
• Official Symbol: Cd22
• Synonyms: CD22; CD22 molecule; B-cell receptor CD22; CD22 antigen

Gene Information

• Official Symbol: Cd22
• Synonyms: CD22; CD22 molecule; B-cell receptor CD22; CD22 antigen

Reviews

01/15/2021

The CD22 protein offers numerous advantages in trials and research studies, making it an excellent choice for scientists in need of reliable and high-quality experimental materials.

06/15/2017

Its unique properties make CD22 an invaluable tool for investigating cellular signaling pathways, protein-protein interactions, and membrane dynamics.

02/17/2016

With the CD22 protein and its accompanying technical assistance, I am confident that I can achieve successful outcomes for my research endeavors.

Q&As

How does CD22-targeted immunotherapy differ from traditional chemotherapy?

CD22-targeted immunotherapy is more targeted, specifically attacking cancer cells, whereas chemotherapy affects both healthy and cancerous cells.

Can CD22-targeted therapies be used in combination with other cancer treatments?

Yes, CD22-targeted therapies are often used in combination with chemotherapy or other immunotherapies for enhanced efficacy.

What other diseases involve CD22 as a therapeutic target?

CD22-targeted therapies are being explored for autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus.

Are there any clinical applications of CD22 protein in cancer therapy?

Yes, CD22 is targeted in immunotherapy for B cell malignancies like acute lymphoblastic leukemia (ALL).

What role does CD22 play in B cell function?

CD22 acts as an inhibitory receptor, regulating B cell activation and signaling.